classification. These data were analyzed for the distribution of benign and malignant salivary tumors in minor salivary glands, male to female ratio, age range, and site of occurrence.
Introduction
Salivary gland tumors are rare, comprising less than 3% of all neoplasms of the head and neck region (1) . Tumors of minor salivary gland origin account for less than 25% of all salivary neoplasms (1, 2) . Reports from several parts of the world have shown differences in the incidence of salivary gland tumors. Variation in the frequency of each histological type has also been reported. The estimated global incidence rate ranges from 0.4 to 3.5 cases per 100,000 annually, with the highest percentage of cases occurring in specific populations. Most studies include major and minor salivary gland tumors together, and few articles have examined minor salivary gland tumors separately (3) (4) (5) (6) (7) (8) (9) .
However, varying circumstances have made it difficult to compare the data among various studies of minor salivary gland tumors. For example, there is considerable variability across the studies in relation to diagnostic criteria, which do not always follow the 1991 WHO classification (1) .
Moreover, the relative frequency of individual tumor types in some surveys is biased in favor of malignant tumors, as the material was drawn from major cancer institutes(10-12). Only a few epidemiological studies were not from a cancer institute.
There are numerous studies on the incidence and histological types of salivary gland tumors from areas such as the USA, Brazil, Japan, Jordan, Africa, and Nigeria(3-10).
However, there is little information available about the pattern of their presentation from Asian countries, particularly in India, where epidemiological analyses of these tumors are very scarce (13) .
The purpose of this retrospective, single institutional study was to determine the relative frequency and distribution of the various types of minor salivary gland tumors in an Indian population, and to provide data for comparison with other epidemiological findings in different geographic locations. Demographic data from these studies should provide us with a better understanding of the biological and clinical characteristics of the disease.
Materials and Methods
A total of 74 cases of primary intraoral minor salivary gland tumors, which were diagnosed histologically in the Benign neoplasms were found among people in the age group 41-50 years, whereas malignant lesions were more common in those >50 years. The peak incidence was seen in those 41-50 years in women and those 51-60 years in men.
There was a predominance of men among the malignant tumor cases and of women among the benign neoplasm cases. (Table 1) As shown in Table 2 , 71.6% of all tumors were located in the palate, making it the most common site, followed by the buccal region, the upper lip, the floor of the mouth, and the retromolar region. The palate was also the most common site for both benign and malignant tumors, where 75% and 66.6% of the benign and malignant tumors were located, respectively. Int J Oral-Med Sci 13(2):75-80, 2014 Table 1 Age and sex distribution of benign and malignant minor salivary gland tumors (n=74) Histologically, benign tumors were all pleomorphic adenomas, except for one case of myoepithelioma, which was found in the left upper labial mucosa in a 66-year-old woman.
Pleomorphic adenomas accounted for 58.1% of all tumors and 97.7% of all benign tumors; they were found in 13 male and 30 female patients, showing a marked predilection for females, with a male to female ratio 1: 2.3. (Table 2) Mucoepidermoid carcinoma was the most common malignant tumor, accounting for 21.6% of all tumors and 53.3% of all malignant tumors. The patients ranged in age from 14 to 74 years, with a mean age of 51.8± 21.6 years. In the malignant tumor group, there were 18 male and 12 female patients. The most common site was the palate (66.6%)( Table 2 ).
The second most common malignant tumor of minor salivary gland origin was adenoid cystic carcinoma, accounting for 9.4% of all tumors and 23.3% of malignant tumors. The patients ranged in age from 21 to 83 years, with a mean age of 54.7±18.6 years. There were 2 male and 2 female patients with palatal tumors. Histologically, 4 tumors were poorly differentiated, and the rest were well differentiated. Acinic cell carcinomas were found in two males, both of whom were 55 years old. One tumor was located in the palate, while the other was located in the floor of the mouth.
Histologically, both were of a predominantly solid type. In showing a predominance of benign over malignant tumors, (3, 5, 7, 8, 12, 15, 16) ; in these studies, the percentage of benign tumors varied from 51.3% to 72.1%. In contrast, some studies have shown a predominance of malignant over benign tumors; in these studies, the percentage of malignant tumors was reported to be 87%, 88.2%, 51.4%, 65.3%, and 76.3%(2,9-12). However, these studies were from special institutions, such as major cancer referral centers. Thus, the relative incidence of benign versus malignant minor salivary gland tumors reflects the character of each institution.
Considering that these high incidences of malignant tumors have been reported mainly from cancer referral centers, it is probably more accurate to consider that the real prevalence of benign and malignant minor salivary gland tumors may show only a slight predominance of malignant tumors.
In the present study, the palate was the most common site for minor salivary gland tumors, with a high frequency of involvement (71.6%). Moreover, the percentage of palatal cases was higher among benign tumors (75%) than among malignant tumors (66.6%). Major studies have also reported that the palate was the most common site for minor salivary gland tumors, and that approximately 40-80% of all tumors occurred in this site (2) (3) (4) (5) (6) (7) (8) (9) . It has also been reported that the percentage of benign tumors was higher than that of malignant tumors in the palate (2, 3, (5) (6) (7) (8) , and that the palate was the predominant site even for malignant minor salivary gland tumors, (3, 5, 8, 10, 16) as in the present study.
In most studies, pleomorphic adenoma is the most common minor salivary gland tumor, (3, 8, 11, 16) with an incidence ranging from 33% (15) adenomas. In the studies from Japan, 62% and 57% of the tumors were classified as pleomorphic adenomas (1) . In the present study, a higher incidence (58.1%) of this tumor was found. These incidences for the Japanese population are higher than those for the population samples in the USA(2-5), the UK,(7) Australia(3), and the Netherlands (15) , in which the percentage of pleomorphic adenomas ranged from 38.1% to 54%. It has been reported that the palate is the most common site for pleomorphic adenomas of minor salivary gland origin (3-8) ; the incidence of palatal involvement has been reported to range from 55.5% to 91% in these studies. In the present study, 76.6% of pleomorphic adenomas occurred in the palate. In the previous reports (4, 5, 7, 8, 11, 16) , the male-to-female ratio for this tumor ranged from 1: 1.1 to 1: 2.5(4,9). The present study The studies prior to 1984 did not recognize polymorphous low grade adenocarcinoma as an entity, and it may have been frequently diagnosed as adenoid cystic carcinoma.
Even after 1984, polymorphous low-grade adenocarcinoma was either not found or reported as a small number in the literature, although a relatively high incidence of this tumor has been reported in several studies from the USA, South Africa, and The Netherlands. In these studies, the incidence of polymorphous low-grade adenocarcinoma was reported to range from 11.0% to 15.7% of all tumors and from 13.8% to 30.6% of malignant tumors. On the other hand, the studies from Japan found no cases of polymorphous lowgrade adenocarcinoma, suggesting the rarity of this tumor, especially in the Japanese population. Also in the present study, the presence of only one case suggests its rarity.
From the results of the present study and a review of the literature, salivary gland tumors in western Uttar Pradesh may be characterized by a higher incidence of benign tumors, especially of pleomorphic adenoma; a more marked tendency for female predominance; a higher incidence of palatal involvement; and a rare occurrence of polymorphous low-grade adenocarcinoma.
Due to the morphological diversity in salivary gland tumors both within and between the different subtypes, the classification of salivary tumors can cause difficulties for those pathologists not used to dealing with such lesions.
Accurate diagnosis is essential, since salivary lesions have diverse clinical and prognostic outcomes. This study has confirmed that some tumors have a predilection for certain sites, and that the risk of malignant disease is greater at specific sites within the oral cavity.
Conclusion:
The results of this study from India show that many clinical characteristics of the disease are similar to those found elsewhere in the world. In order to clarify the geographic variations in the frequency and distribution of the minor salivary gland tumors, further epidemiological data should be accumulated through more extensive studies.
Further epidemiological surveys from India and other Asian
Countries should be encouraged for better understanding of the disease and to provide early and better treatment of salivary gland tumors.
